Page 363 - AIDSBK23C

Page 363

806 Green DA, Masliah E, Vinters HV, Beizai P, Moore DJ, Achim CL. Brain deposition of
beta-amyloid is a common pathologic feature in HIV positive patients. AIDS.
2005;19:407-411.

807 Pulliam L. HIV regulation of amyloid beta production. J Neuroimmune Pharmacol.
2009;4:213–217.

808 Robinson-Papp J, Simpson DM. Neuromuscular diseases associated with HIV-1
infection. Muscle Nerve. 2009;40:1043-1053.

809 Working Group of the American Academy of Neurology AIDS Task Force.
Nomenclature and research case definitions for neurologic manifestations of human
immunodeficiency virus-type 1 (HIV-1) infection. Neurology. 1991;41:778-785.

810 Ferrari S, Vento S, Monaco S, Cavallaro T, Cainelli F, Rizzuto N, Temesgen Z. Human
immunodeficiency virus-associated peripheral neuropathies. Mayo Clin Proc.
2006;81:213-219.

811 Gonzalez-Duarte A, Robinson-Papp J, Simpson DM. Diagnosis and management of HIV-
associated neuropathy. Neurol Clin. 2008;26:821-832.

812 Dalakas MC. Peripheral neuropathy and antiretroviral drugs. J Periph Nerv Syst.
2001;6:14-20.

813 Harrison TB, Smith B. Neuromuscular manifestations of HIV/AIDS. J Clin Neuromuscul
Dis. 2011;13(2):68-84.

814 Authier FJ, Chariot P, Gherardi RK. Skeletal muscle involvement in human
immunodeficiency virus (HIV)-infected patients in the era of highly active antiretroviral
therapy (HAART). Muscle Nerve. 2005;32:247-260.

815 Wrzolek MA, Sher JH, Kozlowski PB, Rao C. Skeletal muscle pathology in AIDS: an
autopsy study. Muscle Nerve. 1990;13:508-515.

816 Cupler EJ, Leon-Monzon M, Miller J, Semino-Mora C, Anderson TL, Dalakas MC.
Inclusion body myositis in HIV-1 and HTLV-1 infected patients. Brain. 1996;119(Pt
6):1887-1893.

817 Crum NF. Bacterial pyomyositis in the United States. Am J Med. 2004;117:420-428.

818 Small LN, Ross JJ. Tropical and temperate pyomyositis. Infect Dis Clin North Am.
2005;19981-989.

819 Ali R, Kim JY, Henderson BA. Anterior and adnexal manifestations of HIV/AIDS. Int
Ophthalmol Clin. 2007;47:15-32.